Details of the Drug Reposition

General Information of This Drug (ID: DM8VTF2)

Drug Name
CD19-UCART   DM8VTF2
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphoblastic leukaemia DIS87TGM 2A85 Clinical trial [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Clinical trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03229876) Safety and Efficacy Evaluation of CD19-UCART